AUGUSTINE LAWLOR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for AUGUSTINE LAWLOR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of AUGUSTINE LAWLOR. AUGUSTINE LAWLOR is Director in HUMAN GENOME SCIENCES INC ($HGSI) and Director in Cardiovascular Systems Inc ($RDYN) and Director in CATALYST BIOSCIENCES, INC. ($CBIO) and Director in GLOBEIMMUNE INC ($GBIM) and Chief Operating Officer in LEAP THERAPEUTICS, INC. ($LPTX).
Latest Insider Trading Transactions of AUGUSTINE LAWLOR
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, RDYN, CBIO, GBIM, HGSI, LPTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 4,761 | 0 | 13,192 | 8.4 K to 13.2 K (+56.47 %) |
| Feb 12 2021 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | F | 1.95 | 11,544 | 22,511 | 11,544 | |
| Feb 12 2021 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | J | 1.95 | 571,428 | 1,114,285 | 0 | |
| Jan 28 2021 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Jan 28 2021 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Jan 28 2021 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | A | 2.57 | 150,000 | 385,500 | 150,000 | |
| Jan 28 2021 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | A | 2.57 | 150,000 | 385,500 | 150,000 | |
| Jan 06 2021 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 3,417 | 0 | 8,431 | 5 K to 8.4 K (+68.15 %) |
| Oct 02 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 5,014 | 0 | 5,014 | 0 to 5 K |
| Aug 12 2020 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | A | 1.97 | 75,000 | 147,750 | 75,000 | |
| Aug 11 2020 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 0.00 | 4,661 | 0 | 4,661 | |
| Aug 11 2020 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 2,090 | 0 | 27,408 | 25.3 K to 27.4 K (+8.25 %) |
| Jul 02 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 3,673 | 0 | 24,215 | 20.5 K to 24.2 K (+17.88 %) |
| Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
| Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
| Apr 13 2020 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | A | 1.69 | 50,000 | 84,500 | 50,000 | |
| Apr 03 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 4,934 | 0 | 20,542 | 15.6 K to 20.5 K (+31.61 %) |
| Feb 25 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Sell | S | 6.10 | 69,401 | 423,506 | 0 | 69.4 K to 0 (-100.00 %) |
| Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 3,166 | 0 | 15,608 | 12.4 K to 15.6 K (+25.45 %) |
| Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 3,166 | 0 | 15,608 | 12.4 K to 15.6 K (+25.45 %) |
| Oct 02 2019 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 4,391 | 0 | 12,442 | 8.1 K to 12.4 K (+54.54 %) |
| Aug 13 2019 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 0.00 | 3,088 | 0 | 3,088 | |
| Aug 13 2019 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 1,810 | 0 | 25,318 | 23.5 K to 25.3 K (+7.70 %) |
| Jul 02 2019 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 2,905 | 0 | 8,051 | 5.1 K to 8.1 K (+56.45 %) |
| Jun 17 2019 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 7.46 | 5,000 | 37,300 | 5,000 | |
| Jun 12 2019 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | A | 1.39 | 200,000 | 278,000 | 200,000 | |
| Apr 02 2019 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 2,414 | 0 | 5,146 | 2.7 K to 5.1 K (+88.36 %) |
| Feb 05 2019 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | P | 1.95 | 571,428 | 1,114,285 | 592,797 | |
| Feb 05 2019 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Buy | P | 1.75 | 571,428 | 999,999 | 4,114,804 | 3.5 M to 4.1 M (+16.13 %) |
| Jan 03 2019 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 2,732 | 0 | 2,732 | 0 to 2.7 K |
| Aug 30 2018 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 0.00 | 3,527 | 0 | 3,527 | |
| Aug 30 2018 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 1,960 | 0 | 23,508 | 21.5 K to 23.5 K (+9.10 %) |
| Aug 01 2018 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | J | 6.09 | 21,369 | 130,030 | 21,369 | |
| Jun 15 2018 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 24.94 | 5,000 | 124,700 | 5,000 | |
| Apr 20 2018 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | A | 7.66 | 50,000 | 383,000 | 50,000 | |
| Nov 16 2017 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | P | 6.09 | 1,057,769 | 6,436,524 | 1,057,769 | |
| Nov 16 2017 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Buy | P | 6.09 | 1,057,769 | 6,436,524 | 3,573,376 | 2.5 M to 3.6 M (+42.05 %) |
| Aug 09 2017 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 0.00 | 4,029 | 0 | 4,029 | |
| Aug 09 2017 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 2,417 | 0 | 21,548 | 19.1 K to 21.5 K (+12.63 %) |
| Jul 14 2017 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 4.40 | 10,000 | 44,000 | 10,000 | |
| Jan 23 2017 | LPTX | LEAP THERAPEUTICS, ... | LAWLOR AUGUSTINE | Chief Operating Off ... | Option Exercise | A | 9.90 | 330,303 | 3,270,000 | 330,303 | |
| Aug 10 2016 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 0.00 | 5,949 | 0 | 5,949 | |
| Aug 10 2016 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 2,855 | 0 | 19,001 | 16.1 K to 19 K (+17.68 %) |
| Jun 13 2016 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 1.88 | 7,500 | 14,100 | 7,500 | |
| Mar 18 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.55 | 11,000 | 17,050 | 463,267 | 474.3 K to 463.3 K (-2.32 %) |
| Mar 17 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 2.05 | 2,500 | 5,125 | 474,267 | 476.8 K to 474.3 K (-0.52 %) |
| Mar 14 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.60 | 16,300 | 26,080 | 476,767 | 493.1 K to 476.8 K (-3.31 %) |
| Mar 14 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.35 | 200 | 270 | 493,067 | 493.3 K to 493.1 K (-0.04 %) |
| Mar 08 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.10 | 5,000 | 5,500 | 493,267 | 498.3 K to 493.3 K (-1.00 %) |
| Mar 08 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 0.99 | 5,010 | 4,960 | 498,267 | 503.3 K to 498.3 K (-1.00 %) |
| Mar 08 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.05 | 5,000 | 5,250 | 503,277 | 508.3 K to 503.3 K (-0.98 %) |
| Mar 03 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.15 | 990 | 1,139 | 508,277 | 509.3 K to 508.3 K (-0.19 %) |
| Mar 03 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.19 | 10,000 | 11,900 | 509,267 | 519.3 K to 509.3 K (-1.93 %) |
| Mar 03 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 0.94 | 5,000 | 4,700 | 519,267 | 524.3 K to 519.3 K (-0.95 %) |
| Feb 29 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 0.89 | 5,000 | 4,450 | 524,267 | 529.3 K to 524.3 K (-0.94 %) |
| Feb 29 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.00 | 5,000 | 5,000 | 529,267 | 534.3 K to 529.3 K (-0.94 %) |
| Feb 29 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.05 | 5,000 | 5,250 | 534,267 | 539.3 K to 534.3 K (-0.93 %) |
| Feb 24 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.17 | 5,000 | 5,850 | 539,267 | 544.3 K to 539.3 K (-0.92 %) |
| Feb 24 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.39 | 5,000 | 6,950 | 544,267 | 549.3 K to 544.3 K (-0.91 %) |
| Feb 24 2016 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Sell | S | 1.43 | 5,000 | 7,150 | 549,267 | 554.3 K to 549.3 K (-0.90 %) |
| Oct 26 2015 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 4.40 | 6,750 | 29,700 | 6,750 | |
| Oct 26 2015 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 4.40 | 8,250 | 36,300 | 8,250 | |
| Aug 20 2015 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | J | 3.33 | 14,056 | 46,806 | 14,056 | |
| Aug 20 2015 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | J | 3.33 | 11,383 | 37,905 | 11,383 | |
| Aug 20 2015 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | J | 33.27 | 2,254 | 74,991 | 2,254 | |
| Aug 20 2015 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Buy | J | 0.00 | 1,041,024 | 0 | 1,041,024 | 0 to 1 M |
| Aug 12 2015 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 0.00 | 5,294 | 0 | 5,294 | |
| Aug 12 2015 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 2,541 | 0 | 16,146 | 13.6 K to 16.1 K (+18.68 %) |
| Jul 13 2015 | GBIM | GLOBEIMMUNE INC | LAWLOR AUGUSTINE | Director | Option Exercise | A | 2.56 | 1,697 | 4,344 | 1,697 | |
| Mar 04 2004 | HGSI | HUMAN GENOME SCIEN ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 12.93 | 48,000 | 620,640 | 48,000 | |
| Mar 04 2004 | HGSI | HUMAN GENOME SCIEN ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 12.93 | 48,000 | 620,640 | 48,000 |
Page: 1